Yang Y - Search Results

1

A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines.

Patel DM, Mateen R, Qaddour N, Carrillo A, Verschraegen C, Yang Y, Li Z, Sundi D, Mortazavi A, Collier KA. Patel DM, et al. Among authors: yang y. Cancers (Basel). 2024 Jan 12;16(2):335. doi: 10.3390/cancers16020335. Cancers (Basel). 2024. PMID: 38254823 Free PMC article. Review.

2

Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin.

Patel SH, George TL, Wang TF, Vogt SM, Folefac E, Xu M, Yang Y, Parikh AB, Verschraegen CF, Clinton SK, Yin M. Patel SH, et al. Among authors: yang y. Cancer. 2021 Mar 15;127(6):938-945. doi: 10.1002/cncr.33337. Epub 2020 Nov 20. Cancer. 2021. PMID: 33216354 Free article.

3

Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy.

Parikh AB, Zhong X, Mellgard G, Qin Q, Patel VG, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher EJ, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh WK, Tsao CK. Parikh AB, et al. Among authors: yang y. Am J Clin Oncol. 2021 Mar 1;44(3):114-120. doi: 10.1097/COC.0000000000000793. Am J Clin Oncol. 2021. PMID: 33417323 Free PMC article.

4

Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.

Johnson K, Issa M, Parikh A, Monk P, Yin M, Mortazavi A, Yang Y. Johnson K, et al. Among authors: yang y. BMC Urol. 2021 Apr 1;21(1):51. doi: 10.1186/s12894-021-00825-4. BMC Urol. 2021. PMID: 33794867 Free PMC article.

5

Salvage nivolumab and ipilimumab after prior anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma: A meta-analysis.

Yang Y, Mori SV, Li M, Hinkley M, Parikh AB, Collier KA, Miah A, Yin M. Yang Y, et al. Cancer Med. 2022 Apr;11(7):1669-1677. doi: 10.1002/cam4.4587. Epub 2022 Feb 9. Cancer Med. 2022. PMID: 35138046 Free PMC article.

6

Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma.

Yang Y, Psutka SP, Parikh AB, Li M, Collier K, Miah A, Mori SV, Hinkley M, Tykodi SS, Hall E, Thompson JA, Yin M. Yang Y, et al. Cancer Med. 2022 Aug;11(16):3106-3114. doi: 10.1002/cam4.4679. Epub 2022 Mar 18. Cancer Med. 2022. PMID: 35304832 Free PMC article.

7

Sex-biased adaptive immune regulation in cancer development and therapy.

Schafer JM, Xiao T, Kwon H, Collier K, Chang Y, Abdel-Hafiz H, Bolyard C, Chung D, Yang Y, Sundi D, Ma Q, Theodorescu D, Li X, Li Z. Schafer JM, et al. Among authors: yang y. iScience. 2022 Jul 4;25(8):104717. doi: 10.1016/j.isci.2022.104717. eCollection 2022 Aug 19. iScience. 2022. PMID: 35880048 Free PMC article. Review.

8

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy.

Gross EE, Li M, Yin M, Orcutt D, Hussey D, Trott E, Holt SK, Dwyer ER, Kramer J, Oliva K, Gore JL, Schade GR, Lin DW, Tykodi SS, Hall ET, Thompson JA, Parikh A, Yang Y, Collier KA, Miah A, Mori-Vogt S, Hinkley M, Mortazavi A, Monk P, Folefac E, Clinton SK, Psutka SP. Gross EE, et al. Among authors: yang y. Urol Oncol. 2023 Jan;41(1):51.e25-51.e31. doi: 10.1016/j.urolonc.2022.08.013. Epub 2022 Oct 26. Urol Oncol. 2023. PMID: 36441070 Free PMC article.

9

Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma.

Kwok C, Khorasanchi A, Psutka SP, Hinkley M, Dason S, Sundi D, Yang Y, Yang Y, Verschraegen C, Gross EE, Orcutt D, Yin M. Kwok C, et al. Among authors: yang y. Front Oncol. 2023 Jul 27;13:1231831. doi: 10.3389/fonc.2023.1231831. eCollection 2023. Front Oncol. 2023. PMID: 37576889 Free PMC article.

10

Emerging Immunotherapy Approaches for Treating Prostate Cancer.

Meng L, Yang Y, Mortazavi A, Zhang J. Meng L, et al. Among authors: yang y. Int J Mol Sci. 2023 Sep 20;24(18):14347. doi: 10.3390/ijms241814347. Int J Mol Sci. 2023. PMID: 37762648 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109,848 results

Search Page

Filters